Clinical Trial Update: Anti-CGRP for Inflammation and Pain Modulation in Small Fiber Neuropathy/Fibromyalgia [Phase 4]

View source ↗

Summary

Duke University completed a Phase 4 trial evaluating anti-CGRP therapy for inflammation and pain modulation in small fiber neuropathy and fibromyalgia; results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia
• Glossopharyngeal Neuralgia
• Small Fiber Neuropathy
• Trigeminal Neuralgia

Drugs mentioned

• Anti-CGRP therapy

Snippet

Sponsor: Duke University | Conditions: Trigeminal Neuralgia, Glossopharyngeal Neuralgia | Phase 4 | Status: COMPLETED | Results posted: 2026-02-02